- Home
- GPRO vs FENC Comparison
GPRO vs FENC Comparison
Compare GPRO & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- FENC
- Stock Information
- Founded
- GPRO 2004
- FENC 1996
- Country
- GPRO United States
- FENC United States
- Employees
- GPRO N/A
- FENC N/A
- Industry
- GPRO Industrial Machinery/Components
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GPRO Consumer Discretionary
- FENC Health Care
- Exchange
- GPRO Nasdaq
- FENC Nasdaq
- Market Cap
- GPRO 193.5M
- FENC 172.8M
- IPO Year
- GPRO 2014
- FENC 2001
- Fundamental
- Price
- GPRO $1.06
- FENC $5.72
- Analyst Decision
- GPRO Hold
- FENC Strong Buy
- Analyst Count
- GPRO 1
- FENC 2
- Target Price
- GPRO $1.50
- FENC $14.00
- AVG Volume (30 Days)
- GPRO 1.5M
- FENC 77.3K
- Earning Date
- GPRO 02-05-2025
- FENC 11-07-2024
- Dividend Yield
- GPRO N/A
- FENC N/A
- EPS Growth
- GPRO N/A
- FENC N/A
- EPS
- GPRO N/A
- FENC N/A
- Revenue
- GPRO $896,011,000.00
- FENC $49,348,000.00
- Revenue This Year
- GPRO N/A
- FENC $170.43
- Revenue Next Year
- GPRO N/A
- FENC $6.70
- P/E Ratio
- GPRO N/A
- FENC N/A
- Revenue Growth
- GPRO N/A
- FENC 278.09
- 52 Week Low
- GPRO $1.03
- FENC $3.96
- 52 Week High
- GPRO $3.40
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- GPRO 36.93
- FENC 44.56
- Support Level
- GPRO $1.03
- FENC $5.61
- Resistance Level
- GPRO $1.19
- FENC $6.19
- Average True Range (ATR)
- GPRO 0.05
- FENC 0.28
- MACD
- GPRO -0.00
- FENC -0.10
- Stochastic Oscillator
- GPRO 19.35
- FENC 11.58
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.